US Stock MarketDetailed Quotes

NVCT Nuvectis Pharma

Watchlist
  • 6.360
  • -0.040-0.62%
Trading May 13 12:21 ET
116.75MMarket Cap-4510P/E (TTM)

Nuvectis Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Nuvectis Pharma Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.25

+7.41%
Analyst Rating

Buy

Apr 8, 2024

Nuvectis Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--

Unlock Free Earnings Estimates

Nuvectis Pharma Earnings Reports

  • Nuvectis Pharma | 10-Q: Quarterly report

    May 8 04:38

  • Nuvectis Pharma | 10-K: Annual report

    Mar 6 06:25

  • Nuvectis Pharma: Q3 2023 Earnings Report

    Nov 8, 2023 20:45

  • Nuvectis Pharma | 10-Q: Q2 2023 Earnings Report

    Aug 10, 2023 04:15

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 8, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg